Tobacco Harm Reduction: Turning Global Evidence into Local Action in Nigeria
By Godswill Iboma
Nigeria stands at a critical crossroads in its response to the health burden associated with smoking. While some argue that preventing tobacco use and helping people quit remain essential public-health priorities, a growing global conversation is challenging policymakers to consider a more pragmatic tool: Tobacco Harm Reduction (THR).
At the heart of this approach is a simple principle: for adults who smoke and are unable or unwilling to quit nicotine altogether, moving away from combustible cigarettes to substantially less harmful alternatives may reduce exposure to toxic substances. Products such as nicotine pouches, e-cigarettes and heated tobacco products have therefore become an increasingly important part of the global harm-reduction conversation.
The significance for Nigeria is profound. Countries such as Sweden and Japan have experienced significant declines in smoking prevalence alongside the growing availability and use of alternative nicotine products, prompting renewed interest in how harm reduction can complement conventional tobacco-control measures. For millions of adults who smoke, the proposition is not about choosing between smoking and sudden abstinence; it is about creating realistic pathways towards lower-risk choices.
A credible harm-reduction framework should neither romanticise nicotine use nor stigmatise adults who choose not to quit. Instead, it should provide smokers with accurate information about the relative risks of available products and enable them, in consultation with appropriate health professionals, to make informed decisions.
Yet international evidence alone will not deliver meaningful change in Nigeria. The country needs a locally grounded, evidence-led conversation about what tobacco harm reduction means, who it is intended to benefit and how it can be responsibly implemented.
Nigerians need clear, accessible and culturally relevant information that distinguishes combustible cigarettes from non-combustible nicotine alternatives. Misconceptions, misinformation and stigma can prevent adults who smoke from understanding their options and foregoing them entirely out of ignorance.
Healthcare professionals also have a critical role to play. They need access to credible, independent scientific peer-reviewed evidence and appropriate continuing education to enable them to discuss smoking cessation and harm-reduction options responsibly with patients.
Policymakers, meanwhile, must strike a careful balance. Regulation should protect the public and young people in particular, prevent unintended initiation and address illicit or substandard products, while ensuring that adults who smoke have access to properly regulated options where the evidence supports their use by adult users as part of a broader tobacco-control strategy.
Perhaps most importantly, Nigeria’s approach to harm reduction must be rooted in solutions rather than stigma. For some smokers, quitting nicotine entirely can be difficult despite repeated attempts. Public-health policy should recognise this reality rather than treat it as a failure of willpower. Harm reduction is about meeting people where they are and helping them move towards a lower-risk outcome.
That does not mean abandoning the goal of cessation. Rather, it means recognising that public health can pursue multiple pathways simultaneously: help smokers quit completely, and support those who cannot or will not quit in moving away from the most harmful form of nicotine consumption—combustible tobacco. Nigeria’s size, influence and economic importance give it a unique opportunity to shape the African conversation on tobacco harm reduction.
By engaging seriously with emerging international evidence, Nigeria can develop policies that reflect its own public-health realities rather than simply importing approaches designed for other countries.
A well-regulated market could also generate broader economic opportunities, including employment, investment, innovation and tax revenues, while placing public health at the centre of the regulatory framework.
The success of any THR policy should ultimately be measured by whether it contributes to fewer smokers, reduced exposure to harmful toxins to first and second hand smokers and better overall health outcomes.
Nigeria cannot afford to remain on the sidelines of the global Tobacco Harm Reduction conversation. The country has an opportunity to take what is being learned internationally and translate it into a framework that reflects Nigerian realities, one that is science-led, carefully regulated, youth-protective and firmly focused on improving public health.
By bringing global evidence into a thoughtful local conversation, Nigeria can strengthen its tobacco-control response, expand the choices available to adults who smoke, reduce the burden of smoking-related risks and potentially position itself as a leader in Africa’s evolving public-health landscape.
